Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients

Running, not enrolling · Not applicable

Conditions studied: Head and Neck Cancer

In brief

The goal of this research study is to learn if home-use of devices to identify dehydration risk, when added to standard care, will help to lower hospitalizations and emergency room visits (and related costs) in patients with head and neck cancer. CYCORE is a software-based system that enables comprehensive collection, storage and analysis of information related to cancer research and clinical care. In this study, those in the CYCORE group use devices at home to measure their dehydration risk. This information is monitored by their clinicians. Those in the standard care group complete health based surveys, as do those in the CYCORE group.

Key facts

Study ID

NCT02253238

Run by

M.D. Anderson Cancer Center

People needed

427

Starts

2014-01-07

Expected to finish

2027-04-30

Last updated by the study team

2026-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of any of the following cancers: stage 1-4b (includes 4a) oropharyngeal, hypopharyngeal, nasopharyngeal, salivary gland or oral cavity; stage 3-4b (includes 4a) laryngeal; any unknown primary head and neck cancer with cervical metastasis that will be addressed with treatment to bilateral necks and mucosa; any thyroid cancer that will be addressed with treatment to the bilateral necks; or other head and neck cancers medically approved by one of our Radiation Oncology collaborating MDs
• Currently receiving (or scheduled to receive) radiation treatment for a cancer listed in the inclusion criteria
• Age 18 years or older
• Fluent in English
• Radiation treatment for this cancer was completed (or will be completed) at MD Anderson Cancer Center (Post-RT study only)
• Receiving radiation treatment for this cancer at any site within the MDACC Cancer Network (Cancer Network study only)

You may not qualify if…

• Overt cognitive difficulty demonstrated by not being clearly oriented to person or place or time
• Zubrod Performance Status >2, or self-reports either not being up and about more than 50% of waking hours or unable to provide self-care
• History of current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g. dysphagia due to underlying neurogenic disorder)
• Orthopedic, neurologic, or musculoskeletal disability that would interfere with the functional task of standing on a weight scale
• Scheduled to receive or receiving unilateral radiation treatment for this cancer
• Received previous radiation treatment for head and neck cancer
• Consented to enroll in a trial with a toxicity endpoint
• Undergoing only palliative (not curative) radiation treatment

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.